Definium Therapeutics (DFTX) Net Equity Issued and Repurchased (2021 - 2026)
Definium Therapeutics' Net Equity Issued and Repurchased was $801.17 million in Q2 2026.
Definium Therapeutics (DFTX) Net Equity Issued and Repurchased (2021 - 2026) Analysis & Trends
On a trailing twelve-month basis, Definium Therapeutics' Net Equity Issued and Repurchased was $1.06 billion through Jun 30, 2026, up 332.0% year-over-year; for FY2025, it was $258.86 million, up 3.5% from FY2024.
- Net Equity Issued and Repurchased shows a five-year compound annual growth rate of 29.2% (FY2020 to FY2025).
- In earlier years, Net Equity Issued and Repurchased was $250 million in FY2024, $7.53 million in FY2023 (-82.2%), $42.3 million in FY2022 (-48.4%) and $81.92 million in FY2021 (+13.8%).
- The Q2 2026 figure marks the highest quarterly Net Equity Issued and Repurchased in data going back to Q1 2021.
- The best year-over-year quarter for Net Equity Issued and Repurchased over five years was Q4 2023 (growth of 915.8%); the worst was Q1 2022 (a decline of 99.9%).
- Per Business Quant data, DFTX's Net Equity Issued and Repurchased in the three quarters before Q2 2026 was $3.83 million (Q1 2026), $257.85 million (Q4 2025) and $425,000 (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 653.54 Bn | 572.07 Bn | 17.26 Bn | - |
| 2 | AbbVie | 467.01 Bn | 440.17 Bn | 12.70 Bn | - |
| 3 | Merck | 367.16 Bn | 321.59 Bn | 12.21 Bn | 43.00 Mn |
| 4 | Novartis Ag | 277.56 Bn | 233.43 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 258.23 Bn | 231.79 Bn | 12.86 Bn | 6.00 Mn |
| 6 | Amgen | 224.14 Bn | 179.54 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 187.30 Bn | 161.42 Bn | 6.22 Bn | 9.00 Mn |
| 8 | Pfizer | 163.47 Bn | 110.41 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 133.31 Bn | 105.31 Bn | 2.84 Bn | 47.70 Mn |
| 10 | Definium Therapeutics | 4.00 Bn | 4.00 Bn | - | 801.17 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 801.17 Mn |
| Mar 31, 2026 | 3.83 Mn |
| Dec 31, 2025 | 257.85 Mn |
| Sep 30, 2025 | 425,000.00 |
| Mar 31, 2025 | 579,000.00 |
| Dec 31, 2024 | 245.57 Mn |
| Jun 30, 2024 | 2.73 Mn |
| Mar 31, 2024 | 1.70 Mn |
| Dec 31, 2023 | 7.42 Mn |
| Sep 30, 2023 | -1.74 Mn |
| Jun 30, 2023 | 1.27 Mn |
| Mar 31, 2023 | 583,000.00 |
| Dec 31, 2022 | 730,000.00 |
| Sep 30, 2022 | 40.86 Mn |
| Jun 30, 2022 | 585,000.00 |
| Mar 31, 2022 | 123,000.00 |
| Sep 30, 2021 | -4,000.00 |
| Jun 30, 2021 | -185,000.00 |
| Mar 31, 2021 | 82.11 Mn |
Definium Therapeutics Net Equity Issued and Repurchased API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=DFTX&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "net-equity-issued-and-repurchased", "ticker": "DFTX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=net-equity-issued-and-repurchased&ticker=DFTX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();